Clinical Trials in the U.S. and China
With fully integrated operations to advance your drug development program, Frontage supports early phase clinical studies in the U.S. and Phase I-IV clinical studies in China, with:
- Clinical study design
- Strategic and regulatory consulting
- Project management
- Study monitoring
- Clinical data management
- Pharmacokinetic and pharmacodynamic analysis
- Quality assurance auditing
- Medical writing
- Pharmacovigilance and medical safety monitoring
Frontage clinical research professionals have a successful track record of managing Phase I-IV trials. We operate an 88-bed clinical research center in Hackensack, NJ, and three China SFDA certified, hospital-based clinical research centers in China (Tianjin Teda International Cardiovascular Hospital, First Affiliated Hospital of Jilin University, and First Affiliated Hospital of Nanjing Medical University).
Experienced biometrics associates provide data management (with EDC capability), statistical consulting, programming and analysis, CDISC data mapping and conversion, and medical writing. In addition, our dedicated full time clinical pharmacologists have a range of capabilities -- from simple PK parameter calculations to pharmacokinetic modeling and/or simulations for your needs. And our dedicated pharmacovigilance associates can help you in SAE tracking and reporting, MedDRA coding, and MedWatch Form preparation. At Frontage, you will get cost-effective and integrated services for all of your clinical development needs.